LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: Shared and Distinct Renal Transcriptome Signatures in 3 Standard Mouse Models of Chronic Kidney Disease.

    Marstrand-Jørgensen, Adam B / Sembach, Frederikke Emilie / Bak, Stine Thorhauge / Ougaard, Maria / Christensen-Dalsgaard, Mikkel / Rønn Madsen, Martin / Jensen, Ditte Marie / Secher, Thomas / Heimbürger, Sebastian Møller Nguyen / Fink, Lisbeth N / Hansen, Ditte / Hansen, Henrik H / Østergaard, Mette Viberg / Christensen, Michael / Dalbøge, Louise S

    Nephron

    2024  , Page(s) 1–16

    Abstract: Introduction: Several mouse models with diverse disease etiologies are used in preclinical research for chronic kidney disease (CKD). Here, we performed a head-to-head comparison of renal transcriptome signatures in standard mouse models of CKD to ... ...

    Abstract Introduction: Several mouse models with diverse disease etiologies are used in preclinical research for chronic kidney disease (CKD). Here, we performed a head-to-head comparison of renal transcriptome signatures in standard mouse models of CKD to assess shared and distinct molecular changes in three mouse models commonly employed in preclinical CKD research and drug discovery.
    Methods: All experiments were conducted on male C57BL/6J mice. Mice underwent sham, unilateral ureter obstruction (UUO), or unilateral ischemic-reperfusion injury (uIRI) surgery and were terminated two- and 6-weeks post-surgery, respectively. The adenine-supplemented diet-induced (ADI) model of CKD was established by feeding with adenine diet for 6 weeks and compared to control diet feeding. For all models, endpoints included plasma biochemistry, kidney histology, and RNA sequencing.
    Results: All models displayed increased macrophage infiltration (F4/80 IHC) and fibrosis (collagen 1a1 IHC). Compared to corresponding controls, all models were characterized by an extensive number of renal differentially expressed genes (≥11,000), with a notable overlap in transcriptomic signatures across models. Gene expression markers of fibrosis, inflammation, and kidney injury supported histological findings. Interestingly, model-specific transcriptome signatures included several genes representing current drug targets for CKD, emphasizing advantages and limitations of the three CKD models in preclinical target and drug discovery.
    Conclusion: The UUO, uIRI, and ADI mouse models of CKD have significant commonalities in their renal global transcriptome profile. Model-specific renal transcriptional signatures should be considered when selecting the specific model in preclinical target and drug discovery.
    Language English
    Publishing date 2024-02-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 207121-6
    ISSN 2235-3186 ; 1423-0186 ; 1660-8151 ; 0028-2766
    ISSN (online) 2235-3186 ; 1423-0186
    ISSN 1660-8151 ; 0028-2766
    DOI 10.1159/000535918
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study).

    Møller, Marie / Borg, Rikke / Bressendorff, Iain / Fink, Lisbeth N / Gravesen, Eva / Jensen, Karina Haar / Hansen, Torben / Krustrup, Dorrit / Persson, Frederik / Rossing, Peter / Sembach, Frederikke E / Thuesen, Anne C B / Hansen, Ditte

    BMJ open

    2023  Volume 13, Issue 6, Page(s) e072216

    Abstract: Introduction: Diabetic kidney disease is a severe complication of diabetes. The diagnosis is based on clinical characteristics such as persistently elevated albuminuria, hypertension and decline in kidney function, although this definition is not ... ...

    Abstract Introduction: Diabetic kidney disease is a severe complication of diabetes. The diagnosis is based on clinical characteristics such as persistently elevated albuminuria, hypertension and decline in kidney function, although this definition is not specific to kidney disease caused by diabetes. The only way to establish an accurate diagnosis-diabetic nephropathy-is by performing a kidney biopsy. The histological presentation of diabetic nephropathy can be associated with a heterogeneous range of histological features with many pathophysiological factors involved demonstrating the complexity of the condition. Current treatment strategies aim to slow disease progression and are not specific to the underlying pathological processes.This study will investigate the prevalence of diabetic nephropathy in individuals with type 2 diabetes (T2D) and severely elevated albuminuria. The deep molecular characterisation of the kidney biopsy and biological specimens may pave the way for improved diagnostic accuracy and a better understanding of the pathological processes involved and may also reveal new targets for individualised treatment.
    Methods and analysis: In the PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy 2 study, research kidney biopsies will be performed in 300 participants with T2D, urine albumin/creatinine ratio ≥700 mg/g and estimated glomerular filtration ratio >30 mL/min/1.73 m
    Ethics and dissemination: The Danish Regional Committee on Health Research Ethics and the Knowledge Center on Data Protection (in the Capital Region of Denmark) have granted approval for the study. The results will be published in peer-reviewed journals.
    Trial registration number: NCT04916132.
    MeSH term(s) Humans ; Diabetes Mellitus, Type 2/epidemiology ; Albuminuria/epidemiology ; Diabetic Nephropathies/epidemiology ; Prospective Studies ; Glomerular Filtration Rate ; Kidney ; Biopsy
    Language English
    Publishing date 2023-06-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2023-072216
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease.

    Dalbøge, Louise S / Christensen, Michael / Madsen, Martin Rønn / Secher, Thomas / Endlich, Nicole / Drenic', Vedran / Manresa-Arraut, Alba / Hansen, Henrik H / Rune, Ida / Fink, Lisbeth N / Østergaard, Mette V

    Biomedicines

    2022  Volume 10, Issue 7

    Abstract: ... ...

    Abstract Background
    Language English
    Publishing date 2022-07-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines10071661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Rodent models of diabetic kidney disease: human translatability and preclinical validity.

    Sembach, Frederikke E / Østergaard, Mette V / Vrang, Niels / Feldt-Rasmussen, Bo / Fosgerau, Keld / Jelsing, Jacob / Fink, Lisbeth N

    Drug discovery today

    2020  Volume 26, Issue 1, Page(s) 200–217

    Abstract: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD). Except for SGLT2 inhibitors and GLP-1R agonists, there have been few changes in DKD treatment over the past 25 years, when multifactorial intervention was introduced in ...

    Abstract Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD). Except for SGLT2 inhibitors and GLP-1R agonists, there have been few changes in DKD treatment over the past 25 years, when multifactorial intervention was introduced in patients with type 2 diabetes mellitus (T2DM). The unmet clinical need is partly due to the lack of animal models that replicate clinical features of human DKD, which has raised concern about the utility of these models in preclinical drug discovery. In this review, we performed a comprehensive analysis of rodent models of DKD to compare treatment efficacy from preclinical testing with outcome from clinical trials. We also investigated whether rodent models are predictive for clinical outcomes of therapeutic agents in human DKD.
    MeSH term(s) Animals ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetic Nephropathies/etiology ; Diabetic Nephropathies/prevention & control ; Disease Models, Animal ; Drug Discovery/methods ; Drug Discovery/trends ; Humans ; Hypoglycemic Agents/pharmacology ; Reproducibility of Results ; Rodentia ; Translational Research, Biomedical/methods
    Chemical Substances Hypoglycemic Agents
    Language English
    Publishing date 2020-05-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1324988-5
    ISSN 1878-5832 ; 1359-6446
    ISSN (online) 1878-5832
    ISSN 1359-6446
    DOI 10.1016/j.drudis.2020.05.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.

    Østergaard, Mette V / Secher, Thomas / Christensen, Michael / Salinas, Casper Gravesen / Roostalu, Urmas / Skytte, Jacob Lercke / Rune, Ida / Hansen, Henrik H / Jelsing, Jacob / Vrang, Niels / Fink, Lisbeth N

    American journal of physiology. Renal physiology

    2021  Volume 321, Issue 2, Page(s) F149–F161

    Abstract: Hypertension is a critical comorbidity for progression of diabetic kidney disease (DKD). To facilitate the development of novel therapeutic interventions with the potential to control disease progression, there is a need to establish translational animal ...

    Abstract Hypertension is a critical comorbidity for progression of diabetic kidney disease (DKD). To facilitate the development of novel therapeutic interventions with the potential to control disease progression, there is a need to establish translational animal models that predict treatment effects in human DKD. The present study aimed to characterize renal disease and outcomes of standard of medical care in a model of advanced DKD facilitated by adeno-associated virus (AAV)-mediated renin overexpression in uninephrectomized (UNx)
    MeSH term(s) Animals ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Benzhydryl Compounds/pharmacology ; Benzhydryl Compounds/therapeutic use ; Blood Pressure/drug effects ; Diabetic Nephropathies/complications ; Diabetic Nephropathies/drug therapy ; Disease Models, Animal ; Female ; Glucosides/pharmacology ; Glucosides/therapeutic use ; Hypertension/complications ; Hypertension/drug therapy ; Lisinopril/pharmacology ; Lisinopril/therapeutic use ; Mice ; Sodium-Glucose Transporter 2 Inhibitors/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Treatment Outcome
    Chemical Substances Antihypertensive Agents ; Benzhydryl Compounds ; Glucosides ; Sodium-Glucose Transporter 2 Inhibitors ; Lisinopril (E7199S1YWR) ; empagliflozin (HDC1R2M35U)
    Language English
    Publishing date 2021-06-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603837-2
    ISSN 1522-1466 ; 0363-6127
    ISSN (online) 1522-1466
    ISSN 0363-6127
    DOI 10.1152/ajprenal.00154.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease.

    Sembach, Frederikke E / Ægidius, Helene M / Fink, Lisbeth N / Secher, Thomas / Aarup, Annemarie / Jelsing, Jacob / Vrang, Niels / Feldt-Rasmussen, Bo / Rigbolt, Kristoffer T G / Nielsen, Jens C / Østergaard, Mette V

    Disease models & mechanisms

    2021  Volume 14, Issue 10

    Abstract: The current understanding of molecular mechanisms driving diabetic kidney disease (DKD) is limited, partly due to the complex structure of the kidney. To identify genes and signalling pathways involved in the progression of DKD, we compared kidney ... ...

    Abstract The current understanding of molecular mechanisms driving diabetic kidney disease (DKD) is limited, partly due to the complex structure of the kidney. To identify genes and signalling pathways involved in the progression of DKD, we compared kidney cortical versus glomerular transcriptome profiles in uninephrectomized (UNx) db/db mouse models of early-stage (UNx only) and advanced [UNxplus adeno-associated virus-mediated renin-1 overexpression (UNx-Renin)] DKD using RNAseq. Compared to normoglycemic db/m mice, db/db UNx and db/db UNx-Renin mice showed marked changes in their kidney cortical and glomerular gene expression profiles. UNx-Renin mice displayed more marked perturbations in gene components associated with the activation of the immune system and enhanced extracellular matrix remodelling, supporting histological hallmarks of progressive DKD in this model. Single-nucleus RNAseq enabled the linking of transcriptome profiles to specific kidney cell types. In conclusion, integration of RNAseq at the cortical, glomerular and single-nucleus level provides an enhanced resolution of molecular signalling pathways associated with disease progression in preclinical models of DKD, and may thus be advantageous for identifying novel therapeutic targets in DKD.
    MeSH term(s) Animals ; Dependovirus/metabolism ; Diabetic Nephropathies/etiology ; Diabetic Nephropathies/genetics ; Disease Models, Animal ; Female ; Gene Expression Profiling ; Gene Expression Regulation ; Hypertension/complications ; Kidney Cortex/metabolism ; Kidney Cortex/pathology ; Kidney Glomerulus/metabolism ; Kidney Glomerulus/pathology ; Mice, Inbred C57BL ; Renin/metabolism ; Mice
    Chemical Substances Renin (EC 3.4.23.15)
    Language English
    Publishing date 2021-10-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2451104-3
    ISSN 1754-8411 ; 1754-8403
    ISSN (online) 1754-8411
    ISSN 1754-8403
    DOI 10.1242/dmm.049086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.

    Østergaard, Mette V / Pinto, Vanda / Stevenson, Kirsty / Worm, Jesper / Fink, Lisbeth N / Coward, Richard J M

    American journal of physiology. Renal physiology

    2016  Volume 312, Issue 2, Page(s) F312–F321

    Abstract: Diabetic nephropathy (DN) is the leading cause of kidney failure in the world. To understand important mechanisms underlying this condition, and to develop new therapies, good animal models are required. In mouse models of type 1 diabetes, the DBA/2J ... ...

    Abstract Diabetic nephropathy (DN) is the leading cause of kidney failure in the world. To understand important mechanisms underlying this condition, and to develop new therapies, good animal models are required. In mouse models of type 1 diabetes, the DBA/2J strain has been shown to be more susceptible to develop kidney disease than other common strains. We hypothesized this would also be the case in type 2 diabetes. We studied db/db and wild-type (wt) DBA/2J mice and compared these with the db/db BLKS/J mouse, which is currently the most widely used type 2 DN model. Mice were analyzed from age 6 to 12 wk for systemic insulin resistance, albuminuria, and glomerular histopathological and ultrastructural changes. Body weight and nonfasted blood glucose were increased by 8 wk in both genders, while systemic insulin resistance commenced by 6 wk in female and 8 wk in male db/db DBA/2J mice. The urinary albumin-to-creatinine ratio (ACR) was closely linked to systemic insulin resistance in both sexes and was increased ~50-fold by 12 wk of age in the db/db DBA/2J cohort. Glomerulosclerosis, foot process effacement, and glomerular basement membrane thickening were observed at 12 wk of age in db/db DBA/2J mice. Compared with db/db BLKS/J mice, db/db DBA/2J mice had significantly increased levels of urinary ACR, but similar glomerular histopathological and ultrastructural changes. The db/db DBA/2J mouse is a robust model of early-stage albuminuric DN, and its levels of albuminuria correlate closely with systemic insulin resistance. This mouse model will be helpful in defining early mechanisms of DN and ultimately the development of novel therapies.
    MeSH term(s) Albuminuria/etiology ; Albuminuria/metabolism ; Albuminuria/pathology ; Animals ; Blood Glucose ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Diabetic Nephropathies/etiology ; Diabetic Nephropathies/metabolism ; Diabetic Nephropathies/pathology ; Disease Models, Animal ; Female ; Glomerular Basement Membrane/metabolism ; Glomerular Basement Membrane/pathology ; Insulin/blood ; Insulin Resistance/physiology ; Kidney/metabolism ; Kidney/pathology ; Male ; Mice ; Mice, Inbred DBA
    Chemical Substances Blood Glucose ; Insulin
    Language English
    Publishing date 2016-11-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603837-2
    ISSN 1522-1466 ; 0363-6127
    ISSN (online) 1522-1466
    ISSN 0363-6127
    DOI 10.1152/ajprenal.00451.2016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Automated Image Analyses of Glomerular Hypertrophy in a Mouse Model of Diabetic Nephropathy.

    Østergaard, Mette V / Sembach, Frederikke E / Skytte, Jacob L / Roostalu, Urmas / Secher, Thomas / Overgaard, Agnete / Fink, Lisbeth N / Vrang, Niels / Jelsing, Jacob / Hecksher-Sørensen, Jacob

    Kidney360

    2020  Volume 1, Issue 6, Page(s) 469–479

    Abstract: Background: Glomerular hypertrophy is a hallmark of kidney injury in metabolically induced renal diseases such as obesity-associated glomerulopathies and diabetic nephropathy (DN).: Methods: Using light sheet fluorescent microscopy (LSFM) and 3D ... ...

    Abstract Background: Glomerular hypertrophy is a hallmark of kidney injury in metabolically induced renal diseases such as obesity-associated glomerulopathies and diabetic nephropathy (DN).
    Methods: Using light sheet fluorescent microscopy (LSFM) and 3D image analysis, we tested algorithms for automated and unbiased quantification of total glomerular numbers and individual glomerular volume in the uninephrectomized (UNx) db/db mouse model of DN.
    Results: At 6 weeks after surgery, db/db and UNx db/db mice showed increased urine albumin-to-creatinine ratio (ACR) compared with db/+ control mice. Before euthanasia, glomeruli were labeled
    Conclusions: Overall, LSFM coupled with automated 3D histomorphometric analysis was demonstrated to be advantageous for unbiased assessment of glomerular volume and numbers in mouse whole-kidney samples. Furthermore, we showed that injection of fluorescently labeled lectin and albumin can be used as markers of nephron segments in the mouse kidneys, thus enabling functional assessment of kidney physiology, pathology, and pharmacology in preclinical rodent models of kidney disease.
    MeSH term(s) Animals ; Diabetes Mellitus/pathology ; Diabetic Nephropathies/pathology ; Hypertrophy/pathology ; Kidney/pathology ; Kidney Glomerulus/pathology ; Mice ; Mice, Inbred Strains
    Language English
    Publishing date 2020-05-01
    Publishing country United States
    Document type Journal Article
    ISSN 2641-7650
    ISSN (online) 2641-7650
    DOI 10.34067/KID.0001272019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications.

    Pillon, Nicolas J / Bilan, Philip J / Fink, Lisbeth N / Klip, Amira

    American journal of physiology. Endocrinology and metabolism

    2013  Volume 304, Issue 5, Page(s) E453–65

    Abstract: Skeletal muscles contain resident immune cell populations and their abundance and type is altered in inflammatory myopathies, endotoxemia or different types of muscle injury/insult. Within tissues, monocytes differentiate into macrophages and polarize to ...

    Abstract Skeletal muscles contain resident immune cell populations and their abundance and type is altered in inflammatory myopathies, endotoxemia or different types of muscle injury/insult. Within tissues, monocytes differentiate into macrophages and polarize to acquire pro- or anti-inflammatory phenotypes. Skeletal muscle macrophages play a fundamental role in repair and pathogen clearance. These events require a precisely regulated cross-talk between myofibers and immune cells, involving paracrine/autocrine and contact interactions. Skeletal muscle also undergoes continuous repair as a result of contractile activity that involves participation of myokines and anti-inflammatory input. Finally, skeletal muscle is the major site of dietary glucose disposal; therefore, muscle insulin resistance is essential to the development of whole body insulin resistance. Notably, muscle inflammation is emerging as a potential contributor to insulin resistance. Recent reports show that inflammatory macrophage numbers within muscle are elevated during obesity and that muscle cells in vitro can mount autonomous inflammatory responses under metabolic challenge. Here, we review the nature of skeletal muscle inflammation associated with muscle exercise, damage, and regeneration, endotoxin presence, and myopathies, as well as the new evidence of local inflammation arising with obesity that potentially contributes to insulin resistance.
    MeSH term(s) Animals ; Diabetes Mellitus/physiopathology ; Dietary Fats/pharmacology ; Humans ; Immune System/physiology ; Inflammation Mediators/metabolism ; Inflammation Mediators/physiology ; Macrophages/immunology ; Muscle, Skeletal/metabolism ; Muscle, Skeletal/physiology ; Muscular Diseases/metabolism ; Muscular Diseases/physiopathology ; Obesity/physiopathology ; Receptor Cross-Talk/physiology
    Chemical Substances Dietary Fats ; Inflammation Mediators
    Language English
    Publishing date 2013-03-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00553.2012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: An Aldehyde Responsive, Cleavable Linker for Glucose Responsive Insulins.

    Mannerstedt, Karin / Mishra, Narendra Kumar / Engholm, Ebbe / Lundh, Morten / Madsen, Charlotte S / Pedersen, Philip J / Le-Huu, Priska / Pedersen, Søren L / Buch-Månson, Nina / Borgström, Björn / Brimert, Thomas / Fink, Lisbeth N / Fosgerau, Keld / Vrang, Niels / Jensen, Knud J

    Chemistry (Weinheim an der Bergstrasse, Germany)

    2021  Volume 27, Issue 9, Page(s) 3166–3176

    Abstract: A glucose responsive insulin (GRI) that responds to changes in blood glucose concentrations has remained an elusive goal. Here we describe the development of glucose cleavable linkers based on hydrazone and thiazolidine structures. We developed linkers ... ...

    Abstract A glucose responsive insulin (GRI) that responds to changes in blood glucose concentrations has remained an elusive goal. Here we describe the development of glucose cleavable linkers based on hydrazone and thiazolidine structures. We developed linkers with low levels of spontaneous hydrolysis but increased level of hydrolysis with rising concentrations of glucose, which demonstrated their glucose responsiveness in vitro. Lipidated hydrazones and thiazolidines were conjugated to the LysB29 side-chain of HI by pH-controlled acylations providing GRIs with glucose responsiveness confirmed in vitro for thiazolidines. Clamp studies showed increased glucose infusion at hyperglycemic conditions for one GRI indicative of a true glucose response. The glucose responsive cleavable linker in these GRIs allow changes in glucose levels to drive the release of active insulin from a circulating depot. We have demonstrated an unprecedented, chemically responsive linker concept for biopharmaceuticals.
    MeSH term(s) Acylation ; Aldehydes/chemistry ; Animals ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; CHO Cells ; Cricetulus ; Humans ; Hydrazones/chemistry ; Insulin/chemistry ; Insulin/metabolism ; Insulin/pharmacology ; Receptor, Insulin/genetics ; Receptor, Insulin/metabolism ; Thiazolidines/chemistry
    Chemical Substances Aldehydes ; Blood Glucose ; Hydrazones ; Insulin ; Thiazolidines ; Receptor, Insulin (EC 2.7.10.1)
    Language English
    Publishing date 2021-01-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1478547-X
    ISSN 1521-3765 ; 0947-6539
    ISSN (online) 1521-3765
    ISSN 0947-6539
    DOI 10.1002/chem.202004878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top